Abstract
[Author declined to make full text available]At the outset of my PhD, my broad aims were to first characterise the expression of APP within the enteric nervous system (ENS) of wild-type (WT) animals, using immunohistochemistry (IHC). Following this, I then set out to characterise the expression of Aβ within the ENS of a transgenic model displaying an overexpression of amyloid precursor protein (APP) and subsequent increase in Aβ (APP-PSEN1 model). I then endeavoured to determine whether Alzheimer’s disease (AD) pathology, namely amyloid-β (Aβ), alters the expression of key neurotransmitter and inflammatory systems within the ENS, using the APP-PSEN1 model, and how these changes affect gastrointestinal (GI) functionality, in terms of colonic contractility and motility, expression of key neurotransmitter-related proteins involved in motility, and expression of genes related to inflammation. In addition, I sought to explore whether stress (acute- restraint stress) causes alterations, at the mRNA level, of molecular machinery involved in inflammation within the colon
| Date of Award | Aug 2021 |
|---|---|
| Original language | English |
| Awarding Institution |
|
| Supervisor | James Brown (Supervisor) & Jerome Swinny (Supervisor) |